Trevena Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.1700
- Today's High:
- $0.1800
- Open Price:
- $0.1700
- 52W Low:
- $0.15
- 52W High:
- $1.05
- Prev. Close:
- $0.1735
- Volume:
- 417775
Company Statistics
- Market Cap.:
- $0.030 billion
- Book Value:
- 0.217
- Revenue TTM:
- $0.000 billion
- Operating Margin TTM:
- -29500%
- Gross Profit TTM:
- $0.000 billion
- Gross Profit TTM:
- $0.000 billion
- Profit Margin:
- 0%
- Return on Assets TTM:
- -41.7%
- Return on Equity TTM:
- -93.5%
Company Profile
Trevena Inc had its IPO on 2014-01-31 under the ticker symbol TRVN.
The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Trevena Inc has a staff strength of 0 employees.
Stock update
Shares of Trevena Inc opened at $0.17 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $0.17 - $0.18, and closed at $0.17.
This is a +0.29% increase from the previous day's closing price.
A total volume of 417,775 shares were traded at the close of the day’s session.
In the last one week, shares of Trevena Inc have increased by 0%.
Trevena Inc's Key Ratios
Trevena Inc has a market cap of $0.030 billion, indicating a price to book ratio of 0.823 and a price to sales ratio of 151.1.
In the last 12-months Trevena Inc’s revenue was $0.000 billion with a gross profit of $0.000 billion and an EBITDA of $-0.059 billion. The EBITDA ratio measures Trevena Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Trevena Inc’s operating margin was -29500% while its return on assets stood at -41.7% with a return of equity of -93.5%.
In Q2, Trevena Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 90.4%.
Trevena Inc’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.353 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Trevena Inc’s profitability.
Trevena Inc stock is trading at a EV to sales ratio of 1.138 and a EV to EBITDA ratio of -0.0039. Its price to sales ratio in the trailing 12-months stood at 151.1.
Trevena Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Trevena Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Trevena Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Trevena Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Trevena Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Trevena Inc paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $0.17
- 52-Week High
- $1.05
- 52-Week Low
- $0.15
- Analyst Target Price
- $1.83
Trevena Inc stock is currently trading at $0.17 per share. It touched a 52-week high of $1.05 and a 52-week low of $1.05. Analysts tracking the stock have a 12-month average target price of $1.83.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Trevena Inc
Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)
Most Active
Top Gainers
Top Losers
About
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of new drugs for patients affected by disorders of the central nervous system. The company is headquartered in Chesterbrook, Pennsylvania.